Efficacy of Cenobamate by Focal Seizure Subtypes: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study (S13.006)

To report post-hoc retrospective efficacy data by focal seizure subtypes from 10 US study sites from a global, long-term, open-label phase 3 study.